EEF1A1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, EEF1A1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated EEF1A1 data layer compared with 24 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher EEF1A1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated EEF1A1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC, CCRCC, and PDAC are the cancer types where EEF1A1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSMedianIII,IV0.9250.658.00124view →
CCRCCDFSQuartileAll0.3760.947.00220view →
PDACDFSTertileIII,IV0.1980.600.01212view →
LSCCDFSQuartileII,III,IV0.8870.250.0243view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

EEF1A1–HNSC (DFS)

Kaplan–Meier survival curve for EEF1A1 mass-spec protein-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration